Mental Health Conference Series Evaluation - February 24, 2026

Please select one: *

I am in active clinical practice

I am retired

I am a student

Other

Please score your agreement with or assessment of the following questions and statements by rating on a scale of 1 to 5, with 5 representing the highest level of satisfaction or agreement. *

Scoring Key: 5=Strongly Agree 4= Somewhat agree 3=Neither agree nor disagree 2= Somewhat disagree 1=Strongly disagree NA=Not applicable

	5	4	3	2	1	NA
The skills learned in this CME course enhanced my professional competence.	The skills learned in this CME course enhanced my professional competence. - 5	The skills learned in this CME course enhanced my professional competence. - 4	The skills learned in this CME course enhanced my professional competence. - 3	The skills learned in this CME course enhanced my professional competence. - 2	The skills learned in this CME course enhanced my professional competence. - 1	The skills learned in this CME course enhanced my professional competence. - NA
The skills learned in this CME course will be applied in the treatment of my patients	The skills learned in this CME course will be applied in the treatment of my patients - 5	The skills learned in this CME course will be applied in the treatment of my patients - 4	The skills learned in this CME course will be applied in the treatment of my patients - 3	The skills learned in this CME course will be applied in the treatment of my patients - 2	The skills learned in this CME course will be applied in the treatment of my patients - 1	The skills learned in this CME course will be applied in the treatment of my patients - NA

How confident are you in your ability to: *

5 = High level of confidence 4 = Moderately high level of confidence 3 = Average level of confidence 2 = Low level of confidence 1 = No level of confidence

	5	4	3	2	1
Screen patients for perinatal mood and anxiety disorders (PMADs) and substance use disorders (SUDs) using evidence-based tools.	Screen patients for perinatal mood and anxiety disorders (PMADs) and substance use disorders (SUDs) using evidence-based tools. - 5	Screen patients for perinatal mood and anxiety disorders (PMADs) and substance use disorders (SUDs) using evidence-based tools. - 4	Screen patients for perinatal mood and anxiety disorders (PMADs) and substance use disorders (SUDs) using evidence-based tools. - 3	Screen patients for perinatal mood and anxiety disorders (PMADs) and substance use disorders (SUDs) using evidence-based tools. - 2	Screen patients for perinatal mood and anxiety disorders (PMADs) and substance use disorders (SUDs) using evidence-based tools. - 1
Initiate evidence-based management strategies for pregnant and postpartum patients with PMADs and SUDs.	Initiate evidence-based management strategies for pregnant and postpartum patients with PMADs and SUDs. - 5	Initiate evidence-based management strategies for pregnant and postpartum patients with PMADs and SUDs. - 4	Initiate evidence-based management strategies for pregnant and postpartum patients with PMADs and SUDs. - 3	Initiate evidence-based management strategies for pregnant and postpartum patients with PMADs and SUDs. - 2	Initiate evidence-based management strategies for pregnant and postpartum patients with PMADs and SUDs. - 1
Access statewide or community-based resources to support ongoing care for patients with PMADs and SUDs.	Access statewide or community-based resources to support ongoing care for patients with PMADs and SUDs. - 5	Access statewide or community-based resources to support ongoing care for patients with PMADs and SUDs. - 4	Access statewide or community-based resources to support ongoing care for patients with PMADs and SUDs. - 3	Access statewide or community-based resources to support ongoing care for patients with PMADs and SUDs. - 2	Access statewide or community-based resources to support ongoing care for patients with PMADs and SUDs. - 1

How satisfied or dissatisfied were you with the Speaker's effectiveness in addressing the learning objectives? *

Scoring Key: 5=Strongly satisfied 4= Somewhat satisfied 3=Neither satisfied nor dissatisfied 2= Somewhat dissatisfied 1=Strongly dissatisfied

	5	4	3	2	1
Summarize the incidence and prevalence of perinatal mood and anxiety disorders (PMADs) and substance use disorders (SUDs)	Summarize the incidence and prevalence of perinatal mood and anxiety disorders (PMADs) and substance use disorders (SUDs) - 5	Summarize the incidence and prevalence of perinatal mood and anxiety disorders (PMADs) and substance use disorders (SUDs) - 4	Summarize the incidence and prevalence of perinatal mood and anxiety disorders (PMADs) and substance use disorders (SUDs) - 3	Summarize the incidence and prevalence of perinatal mood and anxiety disorders (PMADs) and substance use disorders (SUDs) - 2	Summarize the incidence and prevalence of perinatal mood and anxiety disorders (PMADs) and substance use disorders (SUDs) - 1
Assess the clinical, maternal, and neonatal consequences of untreated PMADs and SUDs in the perinatal period	Assess the clinical, maternal, and neonatal consequences of untreated PMADs and SUDs in the perinatal period - 5	Assess the clinical, maternal, and neonatal consequences of untreated PMADs and SUDs in the perinatal period - 4	Assess the clinical, maternal, and neonatal consequences of untreated PMADs and SUDs in the perinatal period - 3	Assess the clinical, maternal, and neonatal consequences of untreated PMADs and SUDs in the perinatal period - 2	Assess the clinical, maternal, and neonatal consequences of untreated PMADs and SUDs in the perinatal period - 1
Utilize evidence-based screening tools and treatment strategies to identify and manage PMADs and SUDs	Utilize evidence-based screening tools and treatment strategies to identify and manage PMADs and SUDs - 5	Utilize evidence-based screening tools and treatment strategies to identify and manage PMADs and SUDs - 4	Utilize evidence-based screening tools and treatment strategies to identify and manage PMADs and SUDs - 3	Utilize evidence-based screening tools and treatment strategies to identify and manage PMADs and SUDs - 2	Utilize evidence-based screening tools and treatment strategies to identify and manage PMADs and SUDs - 1
Identify and access statewide resources available to clinicians for the treatment of PMADs and SUDs	Identify and access statewide resources available to clinicians for the treatment of PMADs and SUDs - 5	Identify and access statewide resources available to clinicians for the treatment of PMADs and SUDs - 4	Identify and access statewide resources available to clinicians for the treatment of PMADs and SUDs - 3	Identify and access statewide resources available to clinicians for the treatment of PMADs and SUDs - 2	Identify and access statewide resources available to clinicians for the treatment of PMADs and SUDs - 1

Was this course fair, balanced and without commercial bias? *

Yes

If you checked "No,” please explain why: *

What, if any, new skills/strategies will you apply in your clinical practice? *

If you do not plan to implement any new skills/strategies in your clinical practice, what is keeping you from doing so? *

Please provide any additional comments or suggestions.

Name

Leave this field blank

You are here

Mental Health Conference Series Evaluation - February 24, 2026